Viewing StudyNCT05456256

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 5:51 PM
Last Modification Date: 2024-10-26 @ 2:37 PM
Study NCT ID: NCT05456256
Status: RECRUITING
Last Update Posted: 2024-07-08
First Post: 2022-07-06
Brief Title: A Study of LP-300 with Carboplatin and Pemetrexed in Never Smokers with Advanced Lung Adenocarcinoma
Sponsor: Lantern Pharma Inc
Organization: Lantern Pharma Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Carcinoma Non-Small-Cell Lung
Adenocarcinoma of Lung
Keywords:
Name View
lung cancer View
never smoker View
non smoker View
EGFR View
ALK View
ROS View
MET View
tyrosine kinase inhibitor View
TKI View
pemetrexed View
carboplatin View
NSCLC View
never-smoker View
non-smoker View
TK inhibitor View